Current Legal Status

Active Legislation

Psilocybin remains a controlled substance under Vermont law. A therapeutic access bill passed the Vermont Senate in 2025 and is being debated in the House. Vermont is seen as a likely near-term adopter of a therapeutic program.

Key Legislation

S.114 (2024) proposed a regulated psilocybin therapy program — passed Vermont Senate. H.636 (2025) companion House bill introduced and advancing through committee.

Clinical Trials

University of Vermont Medical Center has research programs. Check ClinicalTrials.gov for Burlington-area enrolling psilocybin studies.

Advocacy Organizations

Vermont Psychedelic Society, Healing Advocacy Fund.